Emerson Investment Management’s AstraZeneca AZN Stock Holding History

Emerson Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.81M	Buy	49,805 +390	+0.8%	+$23.4K	0.53%	64
2015 Q4	$3.35M	Buy	49,415 +267	+0.5%	+$17.5K	0.66%	61
2015 Q3	$3.13M	Buy	49,148 +1,073	+2%	+$70.6K	0.62%	61
2015 Q2	$3.06M	Sell	48,075 -85	-0.2%	-$5.82K	0.57%	60
2015 Q1	$3.3M	Buy	48,160 +865	+2%	+$60.1K	0.6%	61
2014 Q4	$3.33M	Buy	47,295 +130	+0.3%	+$9.31K	0.65%	60
2014 Q3	$3.37M	Buy	47,165 +125	+0.3%	+$9.15K	0.66%	54
2014 Q2	$3.5M	Buy	47,040 +285	+0.6%	+$20.6K	0.69%	54
2014 Q1	$3.03M	Buy	+46,755	New	+$3.02M	0.62%	57

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Emerson Investment Management's AZN Position: Q1 2016 in Review

Emerson Investment Management increased its AstraZeneca (AZN) stake by 0.79% in Q1 2016, buying an estimated $23.4K and bringing the position to 49,805 shares worth $2.81M. The position accounts for 0.53% of the portfolio, ranked #64.

Emerson Investment Management first reported a position in AZN in Q1 2014 and has held it in 9 quarters since. The position peaked at $3.5M in Q2 2014. 390 funds tracked by Wall St. Rank hold AZN as of Q1 2016.

Emerson Investment Management held 49,805 shares of AstraZeneca worth $2.81M as of Q1 2016.
Emerson Investment Management bought 390 AstraZeneca shares in Q1 2016, an estimated $23.4K.
AstraZeneca made up 0.53% of Emerson Investment Management's portfolio in Q1 2016, its #64 holding.
Emerson Investment Management first reported a position in AstraZeneca in Q1 2014 and has held it in 9 quarters since.
Emerson Investment Management's AstraZeneca position peaked at $3.5M in Q2 2014.
390 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2016.

Based on Emerson Investment Management's 13F filing for Q1 2016, filed 9 May 2016.